187 (Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 100 mg)
Pill with imprint 187 is Yellow, Round and has been identified as Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 100 mg. It is supplied by Sun Pharmaceuticals.
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 187
- 25 mg / 100 mg
- 9.00 mm
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceuticals
- Inactive Ingredients
povidone, mannitol, calcium silicate, crospovidone, magnesium silicate, magnesium stearate, aspartame, silicon dioxide colloidal, microcrystalline cellulose, D&C Yellow No. 10, FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|62756-0187||Sun Pharmaceutical Industries Inc.|
|47335-0187||Sun Pharmaceutical Industries Inc.|
Related Images for "187"
More about carbidopa / levodopa
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 74 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- Carbidopa and levodopa
- Carbidopa and levodopa enteral
- Carbidopa and levodopa (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Extended-Release Capsules
- ... +3 more
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.